Research Overview
Recent clinical research on propolis has focused most heavily on cardiometabolic outcomes, particularly glycemic control (fasting blood glucose, insulin, HbA1c, and insulin resistance indices) and related biomarkers such as liver enzymes, as well as anthropometric measures (weight, BMI, waist-related indices) and blood pressure. In parallel, a smaller but notable body of randomized evidence has examined topical or lesion-directed use of propolis (often alongside honey) for herpes simplex virus (HSV) lesions, comparing healing outcomes against standard antiviral therapy (acyclovir).
The strongest evidence from the provided systematic reviews and meta-analyses supports modest improvements in glycemic indices and small reductions in liver enzymes with propolis supplementation in adults, including statistically significant decreases in fasting blood glucose, insulin, HbA1c, HOMA-IR, ALT, and AST, with no clear effect on GGT. Evidence for body composition effects suggests statistically significant but small reductions in weight and BMI, with no consistent effects on waist circumference, fat mass, or blood pressure; reported time-course analyses indicate benefits may plateau after ~8 weeks. For HSV-related outcomes, pooled results from a limited set of studies suggest propolis may accelerate lesion healing compared with acyclovir, while effects on pain appear less clearly different.
Key gaps remain. Across domains, the literature would benefit from larger, higher-quality, longer-duration RCTs with standardized propolis preparations (composition, dose, and bioactive profiling), consistent outcome definitions, and better reporting of adherence and adverse events. For metabolic and hepatic outcomes, more work is needed to establish clinical relevance (beyond statistical significance), durability of effects, and efficacy across specific populations (e.g., diabetes, NAFLD) and concomitant therapies. For HSV and other infectious/dermatologic indications, additional well-controlled trials are needed to confirm comparative effectiveness versus standard antivirals, clarify optimal formulations and dosing regimens, and assess patient-centered outcomes and safety.
1. What conditions has Propolis been studied for?
Glycemic control / metabolic disease-related outcomes: fasting blood glucose, insulin, insulin resistance (HOMA-IR), and HbA1c in adults (systematic review and meta-analysis of RCTs; 21 RCTs included; pooled analyses reported across 24 trials).
Liver enzyme elevations / liver health markers: alanine transaminase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) in adults (same RCT meta-analysis).
Body weight and body composition: weight, BMI, waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), fat mass (FM) (systematic review and dose-response meta-analysis of RCTs; 22 RCTs, 1082 participants).
Blood pressure: systolic BP (SBP) and diastolic BP (DBP) (same body composition/BP meta-analysis).
Herpes simplex infections: cold sores (herpes labialis) and genital herpes—evaluated as a treatment compared with acyclovir (systematic review and meta-analysis; 9 eligible studies).
2. Does it work in treating those conditions? Summarize the evidence.
-
Glycemic indices (adults): Evidence from an RCT meta-analysis suggests propolis improves several glycemic markers versus control:
Fasting blood glucose: WMD −9.75 mg/dL (95% CI −16.14 to −3.35).
Insulin: WMD −1.64 µU/mL (95% CI −2.61 to −0.68).
HbA1c: WMD −0.46% (95% CI −0.71 to −0.21).
HOMA-IR: WMD −0.54 (95% CI −0.98 to −0.09).
Interpretation: results are statistically significant in pooled analyses, but the authors note prior inconsistency across RCTs and call for higher-quality, longer-term trials to confirm.
-
Liver enzymes (adults): The same RCT meta-analysis found small but statistically significant reductions:
ALT: WMD −2.60 IU/L (95% CI −4.58 to −0.61).
AST: WMD −2.07 IU/L (95% CI −3.05 to −1.09).
GGT: no significant effect versus control.
Interpretation: suggests modest improvement in some liver enzymes; clinical significance may vary depending on baseline elevations and underlying liver disease (not specified in the study).
-
Weight/body composition (adults): RCT meta-analysis shows statistically significant but very small average effects:
Weight: WMD −0.37 kg (95% CI −0.63 to −0.12).
BMI: WMD −0.11 kg/m2 (95% CI −0.13 to −0.09).
No significant effects on WC, WHR, FM, HC.
Interpretation: authors explicitly note the anti-obesity effects are small and may not be clinically important.
-
Blood pressure (adults): No significant effects on SBP or DBP in the RCT meta-analysis.
-
Herpes simplex lesions (cold sores/genital herpes): A systematic review/meta-analysis of 9 studies reported propolis had superior healing outcomes compared with acyclovir (reported as statistically significant; p = 0.0001; CI reported in the study as 2.70 to 8.25).
Interpretation: suggests propolis may speed healing of herpetic lesions compared with acyclovir in the included studies, but the study does not provide details on formulation (e.g., topical vs oral), dosing, study quality, or outcomes beyond healing; results should be interpreted in that context.
3. What health benefits does it have?
-
Improved glycemic control markers (based on pooled RCT evidence): lower fasting glucose, insulin, HbA1c, and HOMA-IR versus control.
-
Modest improvements in liver enzymes: small reductions in ALT and AST (no significant effect on GGT).
-
Small reductions in weight and BMI: statistically significant but likely modest in clinical impact on average; effects on other body composition measures were not significant.
-
Potential antiherpetic (wound-healing) benefit: meta-analysis suggests faster healing of herpes simplex lesions compared with acyclovir in included studies.
4. Does it have any downsides or side effects?
The studies reviewed here do not report adverse events, side effects, or safety outcomes, so no evidence-based side-effect profile can be concluded from these summaries alone.
Evidence limitation: Without adverse-event reporting, it is not possible to weigh benefits against harms from these studies.
Practical limitation noted by authors: For metabolic outcomes, the glycemic/liver enzyme meta-analysis calls for “high-quality, long-term RCTs,” implying uncertainty about long-term effectiveness and safety.
Clinical relevance limitation: For weight/BMI, the meta-analysis notes effects are small and may not reach clinical importance, which can be considered a “downside” in terms of expectations and cost/benefit.
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
The studies reviewed here do not evaluate pharmacogenomic effects or genetic subgroup analyses. Therefore, there is no direct evidence here that propolis is beneficial or harmful based on specific genetic variants.
No genotype-stratified outcomes reported for glycemic response, liver enzymes, weight/BP, or herpes healing.
Evidence gap: Future trials would need to measure relevant variants (e.g., those affecting inflammation/oxidative stress pathways, glucose metabolism, or drug metabolism) to make pharmacogenomic claims.
References
-
Effects of Propolis Consumption on Glycemic Indices and Liver Enzymes in Adults: A Grading of Recommendations Assessment, Development, and Valuation-assessed Systematic Review and Dose-Response Meta-analysis
Shaghayegh Adeli, Mahsa Maroofi, Fatemeh Pourteymour Fard Tabrizi, Beitullah Alipour, Marzieh Heidari (2024) -
The Effects of Propolis Consumption on Body Composition and Blood Pressure: A Systematic Review and Dose-Response Meta-Analysis
Mahdi Vajdi, Atefeh Bonyadian, Fatemeh Pourteymour Fard Tabrizi, Reza Hassanizadeh, Nooshin Noshadi (2024) -
Effect of honey and propolis, compared to acyclovir, against Herpes Simplex Virus (HSV)-induced lesions: A systematic review and meta-analysis
Marina Pereira Rocha, Juliana Mendes Amorim, William Gustavo Lima, Júlio César Moreira Brito, Waleska Stephanie da Cruz Nizer (2022)
This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!